Analysts think RCKT stock price could increase by 236%
Jun 12, 2025, 11:25 AM
-2.96%
What does RCKT do
Rocket Pharmaceuticals, based in Cranbury, New Jersey, develops gene therapies for rare pediatric diseases and employs 268 people. The company targets conditions like Fanconi Anemia and Leukocyte Adhesion Deficiency-I.
18 analysts think RCKT stock price will increase by 235.53%. The current median analyst target is $10.20 compared to a current stock price of $3.04. The lowest analysts target is $2.02 and the highest analyst target is $44.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.